SNT Biotech

SNT Biotech is a private, commercial-stage diagnostics company focused on at-home screening tests to enable early detection of conditions like colorectal cancer and diabetes. Its business model centers on providing testing kits and services directly to consumers and through partnerships with health plans and providers, targeting improved preventive care metrics and reduced healthcare costs. The company emphasizes its status as a minority and women-owned business to meet supplier diversity goals. While showing commercial activity, it appears to be in an early revenue phase, leveraging a distribution platform rather than a proprietary technology platform for test development.

Integrated service and distribution platform for at-home test kit fulfillment, patient engagement, sample logistics, and healthcare system integration, utilizing existing FDA-cleared/CLIA-waived diagnostic assays.

SNT Biotech competes in the crowded at-home testing market against major DTC brands (e.g., Everlywell, LetsGetChecked), retail pharmacy chains, and the direct-to-consumer arms of large clinical laboratories like Labcorp and Quest Diagnostics. Its differentiation is its focused B2B2C model targeting health plan metrics and its diversity-owned certification.